Files
Abstract
The goal of this dissertation is to improve understanding and treatment for the chorioretinopathy seen in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) patients by examining the molecular mechanisms and testing potential treatments for LCHADD chorioretinopathy using a novel LCHADD mouse model.